Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000935836-24-000764
Filing Date
2024-12-18
Accepted
2024-12-18 18:52:04
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 7897
  Complete submission text file 0000935836-24-000764.txt   9500
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 415-801-8100
Graham G. Walmsley (Reporting) CIK: 0001777517 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-39712 | Film No.: 241560570